Stock Rich List
#422 on the corporate holders of 813 holders

Frazier Life Sciences VIII, L.P.

10% owner at Arcutis Biotherapeutics.

$240M
in disclosed stock, −$3.9M (−1.59%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
422nd of 813
Companies held
1
Largest holding
ARQT, 100.0% of total
Latest SEC filing
Oct 24, 2023
Listed but not counted
$190

What the $240M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Arcutis Biotherapeutics ARQT
Common Stock
Directly8,764,232$27.17$238M99.3%Form 4, Oct 24, 2023
Arcutis Biotherapeutics ARQT
Common Stock
Through The Heron Living Trust 11/30/200423,688$27.17$644K0.3%Form 4, Oct 24, 2023
Arcutis Biotherapeutics ARQT
Common Stock
Through Topper Family Revocable Trust19,381$27.17$527K0.2%Form 4, Oct 24, 2023
Arcutis Biotherapeutics ARQT
Common Stock
Through Topper Group II LLC11,266$27.17$306K0.1%Form 4, Oct 24, 2023
Arcutis Biotherapeutics ARQT
Common Stock
Through Patrick J. Heron8,687$27.17$236K0.1%Form 4, Oct 24, 2023

Share counts are the amounts Frazier Life Sciences VIII, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Frazier Life Sciences VIII, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Arcutis Biotherapeutics ARQT
Common Stock
FHM Life Sciences VIII, L.L.C.
Held by a company or fund the insider manages
7$27.17$190—Form 4, Oct 24, 2023

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
419Section 32 Fund 1, LP
10% owner, Dave
$244M−$31.8M (−11.50%)
420Fhmls X, L.P.
10% owner, MBX Biosciences
$243M−$46K (−0.02%)
421Third Rock Ventures GP VI, L.P.
10% owner, Septerna
$242M−$1.4M (−0.56%)
422Frazier Life Sciences VIII, L.P.
10% owner, Arcutis Biotherapeutics
$240M−$3.9M (−1.59%)
423Charles F. Dolan 2009 Family Trust Fbo Deborah A. Dolan-sweeney
Insider, MSG Knickerbockers
$239M−$493K (−0.21%)
424Fhm Life Sciences Viii, L.P.
10% owner, Arcutis Biotherapeutics
$237M−$3.8M (−1.59%)
425ICONIQ Strategic Partners VI, L.P.
10% owner, Procore Technologies
$237M−$4.9M (−2.04%)

Other Arcutis Biotherapeutics insiders

All ARQT insiders

Questions

How much stock does Frazier Life Sciences VIII, L.P. own?

Frazier Life Sciences VIII, L.P. holds $239,836,491 in listed stock based on SEC filings and current prices, mostly Arcutis Biotherapeutics (ARQT). That ranks 422nd on the Stock Rich List.

Is this Frazier Life Sciences VIII, L.P.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with SEC filer 1341382, SEC filer 1365617.